NL-OMON24717招募中不适用
A randomized study, PROstate cancer follow-up care in Secondary and Primary hEalth Care (PROSPEC).
Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands0 个研究点目标入组 390 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Men diagnosed with invasive prostate cancer;
- •2.Stage cT1a–cT3; pNx–pN1; R0-1 having completed primary treatment (prostatectomy or radiotherapy);
排除标准
- •1.Primary treatment (prostatectomy, radiotherapy) not completed at least 3 months previously;
- •2.Patients under active surveillance;
研究者
相似试验
尚未招募
不适用
PROSPEC study; PROstate cancer follow-up care in Secondary and Primary hEalth Careprostate cancerNL-OMON48798ederlands Kanker Instituut390
未知
不适用
Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.Prostate cancerJPRN-UMIN000000570J-CaP study group2,000
进行中（未招募）
1 期
Study on patients with recurrence of prostate cancer with PET/MRRadically treated patient for prostate cancer presenting a biochemical recurrence of disease (PSA: > o = 0.2 ng/mL)MedDRA version: 21.1Level: LLTClassification code 10026389Term: Malignant neoplasm of prostateSystem Organ Class: 100000004864EUCTR2018-001036-21-ITOSPEDALE SAN RAFFAELE60
进行中（未招募）
不适用
Partial prostate Ablation versus Radical Treatment (PART): Comparing partial ablation of the prostate to treatment or removal of the whole prostate in men with localised cancer of one side of the prostate onlyCancerProstate cancerISRCTN17249875niversity of Oxford800
招募中
不适用
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000